Crizalk 250mg Capsule

Product Description

Crizalk 250mg contains Crizotinib, an antineoplastic drug classified as a tyrosine kinase inhibitor. It is prescribed to treat Anaplastic Lymphoma Kinase (ALK)-positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic (spread beyond the lungs to other parts of the body).

Precautions and Warnings

Do NOT take Crizalk 250mg if you:

• Are allergic to Crizotinib or any of its ingredients.

Before starting treatment, inform your doctor if you:

• Have a history of kidney, liver, stomach, or heart problems.
• Have low white blood cell levels or an abnormal ECG (heart tracing).
• Experience vision problems or take other medications.

Pregnancy, Birth Control, and Fertility

• Inform your doctor if you are pregnant or planning to conceive.
• Use effective birth control during treatment, as oral contraceptives may not be effective with this medicine.
• Continue using contraception for at least 90 days after completing therapy.
• Consult your doctor for guidance regarding fertility concerns.

Additional Recommendations

• This medication is not recommended for adolescents and children under 18 years of age.
• Use sunscreen or protective clothing to protect your skin from sunburn.

Always take Crizalk 250mg exactly as prescribed and report any unusual symptoms to your doctor promptly.